Pharmacology News

Older adults who took vitamin D with or without omega-3 fatty acid supplementation had a significantly lower rate of autoimmune disease over 5 years compared with those who took placebo, according to findings published in The BMJ.

While the long-acting injectable Apretude was more effective at reducing the incidence of HIV than oral emtricitabine-tenofovir disoproxil fumarate, researchers said it does not justify the higher costs associated with it.

Pregnant women at highest risk for developing preeclampsia, such as those with diabetes and hypertension, are not routinely prescribed aspirin as recommended by guidelines, according to a population-based study.

The FDA recently announced it has expanded its approval of Gilead Sciences’ antiviral drug remdesivir — marketed in the U.S. as Veklury — to allow certain outpatients with COVID-19 to receive it.

Even though the number of patients who visited an acupuncturist about doubled from 2010 to 2019, and insurance coverage for the treatment increased, most patients continued to pay out of pocket, according to recent data.

Opioid overdose deaths among older adults increased significantly from 1999 to 2019, especially among non-Hispanic Black men, according to findings published in JAMA Network Open.

Among young patients with provoked venous thromboembolism, shorter duration of anticoagulation is noninferior to current standard of care, according to the results of the Kids-DOTT randomized trial.

Binge drinking, cigarette smoking and marijuana use at age 18 years were associated with increased odds of prescription drug misuse later in life, according to findings published in JAMA Network Open.

In a new analysis of the REDUCE-IT trial, the treatment effect of icosapent ethyl was consistent across different agents and categories of statins patients were taking.

The FDA granted approval to Quviviq to treat adults with insomnia.